» Articles » PMID: 26473555

Beta-Sitosterol: A Promising but Orphan Nutraceutical to Fight Against Cancer

Overview
Journal Nutr Cancer
Publisher Routledge
Date 2015 Oct 17
PMID 26473555
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

All the currently available cancer therapeutic options are expensive but none of them are safe. However, traditional plant-derived medicines or compounds are relatively safe. One widely known such compound is beta-sitosterol (BS), a plant derived nutrient with anticancer properties against breast cancer, prostate cancer, colon cancer, lung cancer, stomach cancer, ovarian cancer, and leukemia. Studies have shown that BS interfere with multiple cell signaling pathways, including cell cycle, apoptosis, proliferation, survival, invasion, angiogenesis, metastasis and inflammation. Most of the studies are incomplete partly due to the fact that BS is relatively less potent. But the fact that it is generally considered as nontoxic, the opposite of all currently available cancer chemo-therapeutics, is missed by almost all research communities. To offset the lower efficacy of BS, designing BS delivery for "cancer cell specific" therapy hold huge potential. Delivery of BS through liposome is one of such demonstrations that has shown to be highly promising. But further research did not progress neither in the field of drug delivery of BS nor in the field on how BS mediated anticancer activities could be improved, thus making BS an orphan nutraceutical. Therefore, extensive research with BS as potent anticancer nutraceutical is highly recommended.

Citing Articles

β-Sitosterol-Dietary sources and role in cancer and diabetes management.

Adhimoolam K, Sureshbabu A, Smirnova E, Muthuramalingam P, Do Thi C, Senthil K Food Sci Nutr. 2024; 12(11):8870-8886.

PMID: 39619995 PMC: 11606809. DOI: 10.1002/fsn3.4380.


Optimization of ultrasonically extracted β-sitosterol from using response surface methodology.

Raza A, Akhtar M, Maqbool T, Khalil A, Mohamed M Food Sci Nutr. 2024; 12(10):8211-8219.

PMID: 39479613 PMC: 11521630. DOI: 10.1002/fsn3.4215.


Family Malvaceae: a potential source of secondary metabolites with chemopreventive and anticancer activities supported with pharmacokinetic and pharmacodynamic profiles.

Sameh S, Elissawy A, Al-Sayed E, M Labib R, Chang H, Yu S Front Pharmacol. 2024; 15:1465055.

PMID: 39478959 PMC: 11521888. DOI: 10.3389/fphar.2024.1465055.


Modulation of Multidrug Resistance Transporters by Food Components and Dietary Supplements: Implications for Cancer Therapy Efficacy and Safety.

Brodzicka A, Galanty A, Pasko P Curr Issues Mol Biol. 2024; 46(9):9686-9706.

PMID: 39329928 PMC: 11430623. DOI: 10.3390/cimb46090576.


Causal association of dietary factors with five common cancers: univariate and multivariate Mendelian randomization studies.

Yang L, Wang L, Bao E, Wang J, Zhu P Front Nutr. 2024; 11:1428844.

PMID: 39135550 PMC: 11317396. DOI: 10.3389/fnut.2024.1428844.